Study reveals why elderly at more risk from Covid-19
More boosters or combining different vaccine types may work better in elderly, based on Technion insights into the aging immune system.
More boosters or combining different vaccine types may work better in elderly, based on Technion insights into the aging immune system.
Changes in lung tissue indicate preparation for supporting the growth of metastasized breast cancer cells, say Israeli researchers.
BioMilk, ReMilk, Imagindairy and Fantastic Farms are developing real milk or milk proteins in the lab, without harming animals or the environment.
Two months ago, vaccines were seen as the great hope to end Covid-19. Now, as the virus continues to mutate, interest in emerging Israeli treatments is growing fast.
Facing a rising wave of Delta variant infections, Israeli government launches aggressive campaign to have people over 50 receive a third Pfizer shot.
More than 40% of Alabama residents have high blood pressure, and many are uninsured. DarioHealth’s digital solution can help.
MyOR uses AI and predictive parameters to identify babies at risk of developing allergies and offers a holistic approach to prevent it from happening.
Injectable and oral vaccines under development in Israel may prove significant in protecting people from mutations of the SARS-CoV-2 coronavirus.
A three-way kidney swap between patients and their relatives in Israel and Abu Dhabi was made possible by Abraham Accords collaboration.
Israeli-German research duo analyzes mortality data from 104 countries to uncover Covid-19 deaths and quantify the extent of deception or error.
Israel has already started an aggressive campaign to give over-60s a third booster shot. But is it wise? We asked an expert to tell us what we do and don’t know.
How long do antibodies last, which patients get hit the hardest, how does the vaccine handle the Delta variant – the latest scientific findings from Israel.
Instead of despairing, we need a road map of life with viruses. ‘We will always be dealing with pandemics, and we cannot keep stopping the world.’
Research from Hebrew University points to some promising channel blockers that could be studied as antiviral treatments for SARS-CoV-2.
With the immune system, what we don’t know far outweighs what we do. An Israeli startup aims to fill in those all-important gaps.